Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study - Chunyan Lan; Huaiwu Lu; Lin Zhou; Kunlun Liao; Junxiu Liu; Zhiwen Xie; Haixi Liang; Guorong Zou; Ting Yang; Qin Xu; Xin Huang (Cancer Communications, 2024)